nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—myenteric nerve plexus—colon cancer	0.0424	0.296	CbGeAlD
Cyclobenzaprine—HTR2A—vein—colon cancer	0.0273	0.191	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—colon cancer	0.0094	0.0656	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—colon cancer	0.00867	0.0605	CbGeAlD
Cyclobenzaprine—HTR2A—embryo—colon cancer	0.00517	0.0361	CbGeAlD
Cyclobenzaprine—CYP1A2—renal system—colon cancer	0.00501	0.0349	CbGeAlD
Cyclobenzaprine—HTR2A—epithelium—colon cancer	0.00422	0.0295	CbGeAlD
Cyclobenzaprine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00413	0.00488	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Capecitabine—colon cancer	0.00411	0.00485	CcSEcCtD
Cyclobenzaprine—CYP1A2—digestive system—colon cancer	0.00411	0.0287	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Irinotecan—colon cancer	0.00408	0.00481	CcSEcCtD
Cyclobenzaprine—Sweating—Vincristine—colon cancer	0.00408	0.00481	CcSEcCtD
Cyclobenzaprine—HTR2A—smooth muscle tissue—colon cancer	0.00407	0.0284	CbGeAlD
Cyclobenzaprine—Myocardial infarction—Irinotecan—colon cancer	0.00406	0.00479	CcSEcCtD
Cyclobenzaprine—Stomatitis—Irinotecan—colon cancer	0.00404	0.00476	CcSEcCtD
Cyclobenzaprine—Jaundice—Irinotecan—colon cancer	0.00404	0.00476	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Capecitabine—colon cancer	0.00402	0.00474	CcSEcCtD
Cyclobenzaprine—Sweating—Irinotecan—colon cancer	0.00397	0.00468	CcSEcCtD
Cyclobenzaprine—HTR2A—renal system—colon cancer	0.00391	0.0273	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00391	0.00461	CcSEcCtD
Cyclobenzaprine—Dysarthria—Methotrexate—colon cancer	0.0039	0.0046	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Fluorouracil—colon cancer	0.00389	0.00458	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00389	0.00458	CcSEcCtD
Cyclobenzaprine—Libido decreased—Capecitabine—colon cancer	0.00388	0.00457	CcSEcCtD
Cyclobenzaprine—Stomatitis—Fluorouracil—colon cancer	0.00387	0.00456	CcSEcCtD
Cyclobenzaprine—Hallucination—Vincristine—colon cancer	0.0038	0.00448	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Vincristine—colon cancer	0.0038	0.00448	CcSEcCtD
Cyclobenzaprine—Thirst—Capecitabine—colon cancer	0.00378	0.00446	CcSEcCtD
Cyclobenzaprine—Purpura—Capecitabine—colon cancer	0.00373	0.0044	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Fluorouracil—colon cancer	0.0037	0.00436	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Capecitabine—colon cancer	0.00367	0.00433	CcSEcCtD
Cyclobenzaprine—CYP3A4—renal system—colon cancer	0.00362	0.0253	CbGeAlD
Cyclobenzaprine—Osteoarthritis—Capecitabine—colon cancer	0.0036	0.00424	CcSEcCtD
Cyclobenzaprine—Diplopia—Capecitabine—colon cancer	0.0036	0.00424	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00357	0.00421	CcSEcCtD
Cyclobenzaprine—CYP2D6—renal system—colon cancer	0.00357	0.0249	CbGeAlD
Cyclobenzaprine—Hypoaesthesia—Fluorouracil—colon cancer	0.00354	0.00418	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Fluorouracil—colon cancer	0.00353	0.00417	CcSEcCtD
Cyclobenzaprine—Face oedema—Capecitabine—colon cancer	0.00347	0.00409	CcSEcCtD
Cyclobenzaprine—Irritability—Capecitabine—colon cancer	0.00343	0.00405	CcSEcCtD
Cyclobenzaprine—Urinary retention—Capecitabine—colon cancer	0.00342	0.00403	CcSEcCtD
Cyclobenzaprine—Ataxia—Capecitabine—colon cancer	0.00338	0.00399	CcSEcCtD
Cyclobenzaprine—Alopecia—Vincristine—colon cancer	0.00337	0.00398	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Irinotecan—colon cancer	0.00332	0.00392	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Methotrexate—colon cancer	0.0033	0.00389	CcSEcCtD
Cyclobenzaprine—Alopecia—Irinotecan—colon cancer	0.00328	0.00387	CcSEcCtD
Cyclobenzaprine—HTR2A—digestive system—colon cancer	0.00321	0.0224	CbGeAlD
Cyclobenzaprine—Flatulence—Irinotecan—colon cancer	0.00319	0.00376	CcSEcCtD
Cyclobenzaprine—Gastritis—Capecitabine—colon cancer	0.00318	0.00375	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Fluorouracil—colon cancer	0.00318	0.00375	CcSEcCtD
Cyclobenzaprine—Alopecia—Fluorouracil—colon cancer	0.00315	0.00371	CcSEcCtD
Cyclobenzaprine—CYP1A2—liver—colon cancer	0.00306	0.0214	CbGeAlD
Cyclobenzaprine—Agitation—Vincristine—colon cancer	0.00305	0.0036	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Irinotecan—colon cancer	0.003	0.00354	CcSEcCtD
Cyclobenzaprine—Vertigo—Vincristine—colon cancer	0.00298	0.00352	CcSEcCtD
Cyclobenzaprine—Leukopenia—Vincristine—colon cancer	0.00297	0.00351	CcSEcCtD
Cyclobenzaprine—CYP3A4—digestive system—colon cancer	0.00297	0.0207	CbGeAlD
Cyclobenzaprine—Pancytopenia—Capecitabine—colon cancer	0.00295	0.00348	CcSEcCtD
Cyclobenzaprine—CYP2D6—digestive system—colon cancer	0.00292	0.0204	CbGeAlD
Cyclobenzaprine—Vision blurred—Fluorouracil—colon cancer	0.00292	0.00344	CcSEcCtD
Cyclobenzaprine—Malaise—Irinotecan—colon cancer	0.00292	0.00344	CcSEcCtD
Cyclobenzaprine—Vertigo—Irinotecan—colon cancer	0.00291	0.00343	CcSEcCtD
Cyclobenzaprine—Syncope—Irinotecan—colon cancer	0.0029	0.00342	CcSEcCtD
Cyclobenzaprine—Leukopenia—Irinotecan—colon cancer	0.0029	0.00342	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00289	0.00341	CcSEcCtD
Cyclobenzaprine—Convulsion—Vincristine—colon cancer	0.00288	0.0034	CcSEcCtD
Cyclobenzaprine—Hypertension—Vincristine—colon cancer	0.00287	0.00338	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Irinotecan—colon cancer	0.00284	0.00335	CcSEcCtD
Cyclobenzaprine—HTR2A—vagina—colon cancer	0.00284	0.0198	CbGeAlD
Cyclobenzaprine—Myalgia—Vincristine—colon cancer	0.00283	0.00334	CcSEcCtD
Cyclobenzaprine—Weight increased—Capecitabine—colon cancer	0.00283	0.00334	CcSEcCtD
Cyclobenzaprine—Hypertension—Irinotecan—colon cancer	0.00279	0.00329	CcSEcCtD
Cyclobenzaprine—Leukopenia—Fluorouracil—colon cancer	0.00277	0.00327	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Capecitabine—colon cancer	0.00273	0.00322	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Methotrexate—colon cancer	0.00273	0.00322	CcSEcCtD
Cyclobenzaprine—Discomfort—Irinotecan—colon cancer	0.00272	0.00321	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Capecitabine—colon cancer	0.00272	0.0032	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Capecitabine—colon cancer	0.00272	0.0032	CcSEcCtD
Cyclobenzaprine—Oedema—Vincristine—colon cancer	0.00271	0.0032	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Vincristine—colon cancer	0.00271	0.0032	CcSEcCtD
Cyclobenzaprine—Stomatitis—Capecitabine—colon cancer	0.0027	0.00319	CcSEcCtD
Cyclobenzaprine—Jaundice—Capecitabine—colon cancer	0.0027	0.00319	CcSEcCtD
Cyclobenzaprine—Convulsion—Fluorouracil—colon cancer	0.00268	0.00317	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Methotrexate—colon cancer	0.00268	0.00316	CcSEcCtD
Cyclobenzaprine—Confusional state—Irinotecan—colon cancer	0.00266	0.00314	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Vincristine—colon cancer	0.00265	0.00313	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Irinotecan—colon cancer	0.00264	0.00311	CcSEcCtD
Cyclobenzaprine—Oedema—Irinotecan—colon cancer	0.00264	0.00311	CcSEcCtD
Cyclobenzaprine—Myalgia—Fluorouracil—colon cancer	0.00264	0.00311	CcSEcCtD
Cyclobenzaprine—Chest pain—Fluorouracil—colon cancer	0.00264	0.00311	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Vincristine—colon cancer	0.00262	0.00309	CcSEcCtD
Cyclobenzaprine—Discomfort—Fluorouracil—colon cancer	0.00261	0.00307	CcSEcCtD
Cyclobenzaprine—Shock—Irinotecan—colon cancer	0.0026	0.00306	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Capecitabine—colon cancer	0.00259	0.00305	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Irinotecan—colon cancer	0.00259	0.00305	CcSEcCtD
Cyclobenzaprine—Anorexia—Vincristine—colon cancer	0.00258	0.00305	CcSEcCtD
Cyclobenzaprine—Irritability—Methotrexate—colon cancer	0.00255	0.00301	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Irinotecan—colon cancer	0.00255	0.00301	CcSEcCtD
Cyclobenzaprine—Confusional state—Fluorouracil—colon cancer	0.00255	0.00301	CcSEcCtD
Cyclobenzaprine—Hypotension—Vincristine—colon cancer	0.00253	0.00299	CcSEcCtD
Cyclobenzaprine—Oedema—Fluorouracil—colon cancer	0.00253	0.00298	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Fluorouracil—colon cancer	0.00253	0.00298	CcSEcCtD
Cyclobenzaprine—Anorexia—Irinotecan—colon cancer	0.00252	0.00297	CcSEcCtD
Cyclobenzaprine—Ataxia—Methotrexate—colon cancer	0.00252	0.00297	CcSEcCtD
Cyclobenzaprine—Hepatitis—Capecitabine—colon cancer	0.00249	0.00293	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Fluorouracil—colon cancer	0.00248	0.00292	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Capecitabine—colon cancer	0.00248	0.00292	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00247	0.00291	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Capecitabine—colon cancer	0.00247	0.00291	CcSEcCtD
Cyclobenzaprine—Tachycardia—Fluorouracil—colon cancer	0.00247	0.00291	CcSEcCtD
Cyclobenzaprine—Hypotension—Irinotecan—colon cancer	0.00247	0.00291	CcSEcCtD
Cyclobenzaprine—Insomnia—Vincristine—colon cancer	0.00245	0.00289	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vincristine—colon cancer	0.00243	0.00287	CcSEcCtD
Cyclobenzaprine—Anorexia—Fluorouracil—colon cancer	0.00241	0.00284	CcSEcCtD
Cyclobenzaprine—HTR2A—liver—colon cancer	0.00239	0.0167	CbGeAlD
Cyclobenzaprine—Insomnia—Irinotecan—colon cancer	0.00239	0.00282	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Irinotecan—colon cancer	0.00237	0.0028	CcSEcCtD
Cyclobenzaprine—Hypotension—Fluorouracil—colon cancer	0.00236	0.00279	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vincristine—colon cancer	0.00236	0.00278	CcSEcCtD
Cyclobenzaprine—Protriptyline—ABCB1—colon cancer	0.00236	0.264	CrCbGaD
Cyclobenzaprine—Dyspnoea—Irinotecan—colon cancer	0.00235	0.00278	CcSEcCtD
Cyclobenzaprine—Somnolence—Irinotecan—colon cancer	0.00235	0.00277	CcSEcCtD
Cyclobenzaprine—Fatigue—Vincristine—colon cancer	0.00234	0.00276	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Irinotecan—colon cancer	0.00232	0.00274	CcSEcCtD
Cyclobenzaprine—Tinnitus—Capecitabine—colon cancer	0.00232	0.00274	CcSEcCtD
Cyclobenzaprine—Constipation—Vincristine—colon cancer	0.00232	0.00273	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0023	0.00272	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Irinotecan—colon cancer	0.0023	0.00271	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Methotrexate—colon cancer	0.00229	0.0027	CcSEcCtD
Cyclobenzaprine—Insomnia—Fluorouracil—colon cancer	0.00229	0.0027	CcSEcCtD
Cyclobenzaprine—Fatigue—Irinotecan—colon cancer	0.00228	0.00269	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Fluorouracil—colon cancer	0.00227	0.00268	CcSEcCtD
Cyclobenzaprine—Constipation—Irinotecan—colon cancer	0.00226	0.00266	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Fluorouracil—colon cancer	0.00225	0.00266	CcSEcCtD
Cyclobenzaprine—Somnolence—Fluorouracil—colon cancer	0.00225	0.00265	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Fluorouracil—colon cancer	0.00223	0.00263	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Capecitabine—colon cancer	0.00222	0.00262	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vincristine—colon cancer	0.00222	0.00262	CcSEcCtD
Cyclobenzaprine—CYP3A4—liver—colon cancer	0.00221	0.0155	CbGeAlD
Cyclobenzaprine—Decreased appetite—Fluorouracil—colon cancer	0.0022	0.00259	CcSEcCtD
Cyclobenzaprine—Alopecia—Capecitabine—colon cancer	0.0022	0.00259	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—colon cancer	0.0022	0.00259	CcSEcCtD
Cyclobenzaprine—CYP2D6—liver—colon cancer	0.00218	0.0152	CbGeAlD
Cyclobenzaprine—Feeling abnormal—Irinotecan—colon cancer	0.00218	0.00257	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Irinotecan—colon cancer	0.00216	0.00255	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00215	0.00254	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vincristine—colon cancer	0.00214	0.00253	CcSEcCtD
Cyclobenzaprine—Flatulence—Capecitabine—colon cancer	0.00213	0.00252	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—colon cancer	0.00213	0.00251	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Capecitabine—colon cancer	0.00212	0.0025	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Irinotecan—colon cancer	0.00209	0.00246	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Fluorouracil—colon cancer	0.00208	0.00246	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—colon cancer	0.00206	0.00243	CcSEcCtD
Cyclobenzaprine—Vision blurred—Capecitabine—colon cancer	0.00204	0.00241	CcSEcCtD
Cyclobenzaprine—Tremor—Capecitabine—colon cancer	0.00203	0.00239	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—colon cancer	0.00201	0.00237	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Capecitabine—colon cancer	0.00201	0.00237	CcSEcCtD
Cyclobenzaprine—Urticaria—Fluorouracil—colon cancer	0.00201	0.00237	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vincristine—colon cancer	0.002	0.00236	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—colon cancer	0.00198	0.00233	CcSEcCtD
Cyclobenzaprine—Malaise—Capecitabine—colon cancer	0.00195	0.0023	CcSEcCtD
Cyclobenzaprine—Vertigo—Capecitabine—colon cancer	0.00195	0.00229	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Irinotecan—colon cancer	0.00195	0.00229	CcSEcCtD
Cyclobenzaprine—Asthenia—Vincristine—colon cancer	0.00195	0.00229	CcSEcCtD
Cyclobenzaprine—Syncope—Capecitabine—colon cancer	0.00194	0.00229	CcSEcCtD
Cyclobenzaprine—Leukopenia—Capecitabine—colon cancer	0.00194	0.00229	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—colon cancer	0.00193	0.00227	CcSEcCtD
Cyclobenzaprine—Palpitations—Capecitabine—colon cancer	0.00191	0.00226	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Capecitabine—colon cancer	0.0019	0.00224	CcSEcCtD
Cyclobenzaprine—Asthenia—Irinotecan—colon cancer	0.00189	0.00223	CcSEcCtD
Cyclobenzaprine—Hypertension—Capecitabine—colon cancer	0.00187	0.00221	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Fluorouracil—colon cancer	0.00186	0.0022	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vincristine—colon cancer	0.00186	0.00219	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—colon cancer	0.00185	0.00218	CcSEcCtD
Cyclobenzaprine—Myalgia—Capecitabine—colon cancer	0.00184	0.00217	CcSEcCtD
Cyclobenzaprine—Chest pain—Capecitabine—colon cancer	0.00184	0.00217	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—colon cancer	0.00184	0.00217	CcSEcCtD
Cyclobenzaprine—Anxiety—Capecitabine—colon cancer	0.00184	0.00217	CcSEcCtD
Cyclobenzaprine—Discomfort—Capecitabine—colon cancer	0.00182	0.00215	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Irinotecan—colon cancer	0.00181	0.00213	CcSEcCtD
Cyclobenzaprine—Dry mouth—Capecitabine—colon cancer	0.0018	0.00213	CcSEcCtD
Cyclobenzaprine—Dizziness—Vincristine—colon cancer	0.00179	0.00211	CcSEcCtD
Cyclobenzaprine—Pruritus—Fluorouracil—colon cancer	0.00179	0.00211	CcSEcCtD
Cyclobenzaprine—Confusional state—Capecitabine—colon cancer	0.00178	0.0021	CcSEcCtD
Cyclobenzaprine—Oedema—Capecitabine—colon cancer	0.00177	0.00208	CcSEcCtD
Cyclobenzaprine—Dizziness—Irinotecan—colon cancer	0.00175	0.00206	CcSEcCtD
Cyclobenzaprine—Shock—Capecitabine—colon cancer	0.00174	0.00205	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Fluorouracil—colon cancer	0.00173	0.00204	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Capecitabine—colon cancer	0.00173	0.00204	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—colon cancer	0.00173	0.00204	CcSEcCtD
Cyclobenzaprine—Tachycardia—Capecitabine—colon cancer	0.00172	0.00203	CcSEcCtD
Cyclobenzaprine—Vomiting—Vincristine—colon cancer	0.00172	0.00203	CcSEcCtD
Cyclobenzaprine—Rash—Vincristine—colon cancer	0.00171	0.00202	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Capecitabine—colon cancer	0.00171	0.00202	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vincristine—colon cancer	0.00171	0.00201	CcSEcCtD
Cyclobenzaprine—Headache—Vincristine—colon cancer	0.0017	0.002	CcSEcCtD
Cyclobenzaprine—Anorexia—Capecitabine—colon cancer	0.00168	0.00199	CcSEcCtD
Cyclobenzaprine—Vomiting—Irinotecan—colon cancer	0.00168	0.00198	CcSEcCtD
Cyclobenzaprine—Dizziness—Fluorouracil—colon cancer	0.00167	0.00197	CcSEcCtD
Cyclobenzaprine—Rash—Irinotecan—colon cancer	0.00167	0.00196	CcSEcCtD
Cyclobenzaprine—Dermatitis—Irinotecan—colon cancer	0.00166	0.00196	CcSEcCtD
Cyclobenzaprine—Headache—Irinotecan—colon cancer	0.00165	0.00195	CcSEcCtD
Cyclobenzaprine—Hypotension—Capecitabine—colon cancer	0.00165	0.00195	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—colon cancer	0.00164	0.00193	CcSEcCtD
Cyclobenzaprine—Nausea—Vincristine—colon cancer	0.00161	0.0019	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00161	0.0019	CcSEcCtD
Cyclobenzaprine—Vomiting—Fluorouracil—colon cancer	0.00161	0.0019	CcSEcCtD
Cyclobenzaprine—Insomnia—Capecitabine—colon cancer	0.0016	0.00189	CcSEcCtD
Cyclobenzaprine—Rash—Fluorouracil—colon cancer	0.00159	0.00188	CcSEcCtD
Cyclobenzaprine—Dermatitis—Fluorouracil—colon cancer	0.00159	0.00188	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Capecitabine—colon cancer	0.00159	0.00187	CcSEcCtD
Cyclobenzaprine—Headache—Fluorouracil—colon cancer	0.00158	0.00187	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—colon cancer	0.00158	0.00186	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Capecitabine—colon cancer	0.00158	0.00186	CcSEcCtD
Cyclobenzaprine—Nausea—Irinotecan—colon cancer	0.00157	0.00185	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Capecitabine—colon cancer	0.00156	0.00184	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Capecitabine—colon cancer	0.00154	0.00181	CcSEcCtD
Cyclobenzaprine—Fatigue—Capecitabine—colon cancer	0.00152	0.0018	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—colon cancer	0.00152	0.00179	CcSEcCtD
Cyclobenzaprine—Constipation—Capecitabine—colon cancer	0.00151	0.00178	CcSEcCtD
Cyclobenzaprine—Nausea—Fluorouracil—colon cancer	0.0015	0.00177	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—colon cancer	0.0015	0.00176	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Capecitabine—colon cancer	0.00146	0.00172	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—colon cancer	0.00145	0.00171	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—colon cancer	0.00145	0.00171	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Capecitabine—colon cancer	0.00145	0.0017	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—colon cancer	0.00144	0.0017	CcSEcCtD
Cyclobenzaprine—Urticaria—Capecitabine—colon cancer	0.0014	0.00166	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Capecitabine—colon cancer	0.0014	0.00165	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—colon cancer	0.0014	0.00165	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—colon cancer	0.00137	0.00162	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—colon cancer	0.00137	0.00162	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—colon cancer	0.00136	0.0016	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—colon cancer	0.00133	0.00156	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—colon cancer	0.00132	0.00155	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Capecitabine—colon cancer	0.0013	0.00154	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—colon cancer	0.00129	0.00152	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—colon cancer	0.00127	0.0015	CcSEcCtD
Cyclobenzaprine—Asthenia—Capecitabine—colon cancer	0.00127	0.0015	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—colon cancer	0.00125	0.00148	CcSEcCtD
Cyclobenzaprine—Pruritus—Capecitabine—colon cancer	0.00125	0.00147	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—colon cancer	0.00123	0.00145	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Capecitabine—colon cancer	0.00121	0.00143	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0012	0.00141	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—colon cancer	0.00119	0.0014	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—colon cancer	0.00118	0.00139	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—colon cancer	0.00117	0.00138	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—colon cancer	0.00117	0.00138	CcSEcCtD
Cyclobenzaprine—Dizziness—Capecitabine—colon cancer	0.00117	0.00138	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—colon cancer	0.00116	0.00137	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—colon cancer	0.00114	0.00135	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—colon cancer	0.00113	0.00134	CcSEcCtD
Cyclobenzaprine—Vomiting—Capecitabine—colon cancer	0.00112	0.00133	CcSEcCtD
Cyclobenzaprine—Rash—Capecitabine—colon cancer	0.00111	0.00131	CcSEcCtD
Cyclobenzaprine—Dermatitis—Capecitabine—colon cancer	0.00111	0.00131	CcSEcCtD
Cyclobenzaprine—Headache—Capecitabine—colon cancer	0.00111	0.00131	CcSEcCtD
Cyclobenzaprine—Carbamazepine—ABCB1—colon cancer	0.0011	0.123	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Methotrexate—colon cancer	0.00108	0.00128	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—colon cancer	0.00108	0.00127	CcSEcCtD
Cyclobenzaprine—Nausea—Capecitabine—colon cancer	0.00105	0.00124	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—colon cancer	0.00105	0.00123	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—colon cancer	0.00104	0.00123	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—colon cancer	0.000969	0.00114	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—colon cancer	0.000944	0.00111	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—colon cancer	0.000931	0.0011	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—ABCB1—colon cancer	0.00092	0.103	CrCbGaD
Cyclobenzaprine—Diarrhoea—Methotrexate—colon cancer	0.0009	0.00106	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—colon cancer	0.00087	0.00103	CcSEcCtD
Cyclobenzaprine—Trimipramine—ABCB1—colon cancer	0.00085	0.0953	CrCbGaD
Cyclobenzaprine—Vomiting—Methotrexate—colon cancer	0.000837	0.000987	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—colon cancer	0.00083	0.000978	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—colon cancer	0.000829	0.000978	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—colon cancer	0.000824	0.000972	CcSEcCtD
Cyclobenzaprine—Promethazine—ABCB1—colon cancer	0.000819	0.0917	CrCbGaD
Cyclobenzaprine—Tamoxifen—ABCB1—colon cancer	0.000813	0.0911	CrCbGaD
Cyclobenzaprine—Doxepin—ABCB1—colon cancer	0.00081	0.0908	CrCbGaD
Cyclobenzaprine—Nausea—Methotrexate—colon cancer	0.000781	0.000922	CcSEcCtD
Cyclobenzaprine—Imipramine—ABCB1—colon cancer	0.000631	0.0707	CrCbGaD
Cyclobenzaprine—Amitriptyline—ABCB1—colon cancer	0.000627	0.0702	CrCbGaD
